A Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 CEP of the European Pharmacopoeia monograph is often referred to as a Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 Certificate of Suitability (COS). The purpose of a Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 to their clients by showing that a Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 CEP has been issued for it. The manufacturer submits a Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 CEP holder for the record. Additionally, the data presented in the Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 DMF.
A Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116 suppliers with CEP (COS) on PharmaCompass.